313 related articles for article (PubMed ID: 31828868)
1. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of exosomes in multiple myeloma.
Moloudizargari M; Abdollahi M; Asghari MH; Zimta AA; Neagoe IB; Nabavi SM
Blood Rev; 2019 Nov; 38():100595. PubMed ID: 31445775
[TBL] [Abstract][Full Text] [Related]
5. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
Tang JX; Chen Q; Li Q; He YH; Xiao D
Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
[TBL] [Abstract][Full Text] [Related]
6. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
7. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs.
Raimondi L; De Luca A; Gallo A; Costa V; Russelli G; Cuscino N; Manno M; Raccosta S; Carina V; Bellavia D; Conigliaro A; Alessandro R; Fini M; Conaldi PG; Giavaresi G
Carcinogenesis; 2020 Jul; 41(5):666-677. PubMed ID: 31294446
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
Peng Y; Song X; Lan J; Wang X; Wang M
Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
[TBL] [Abstract][Full Text] [Related]
10. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment.
Tang W; Xu J; Xu C
Cancer Lett; 2023 Mar; 556():216081. PubMed ID: 36739065
[TBL] [Abstract][Full Text] [Related]
13. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma.
Chen D; Yang X; Liu M; Zhang Z; Xing E
Cancer Gene Ther; 2021 Dec; 28(12):1256-1268. PubMed ID: 33402729
[TBL] [Abstract][Full Text] [Related]
14. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
Amodio N; Leotta M; Bellizzi D; Di Martino MT; D'Aquila P; Lionetti M; Fabiani F; Leone E; Gullà AM; Passarino G; Caraglia M; Negrini M; Neri A; Giordano A; Tagliaferri P; Tassone P
Oncotarget; 2012 Oct; 3(10):1246-58. PubMed ID: 23100393
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
Soley L; Falank C; Reagan MR
Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment drug resistance in multiple myeloma: emerging new players.
Di Marzo L; Desantis V; Solimando AG; Ruggieri S; Annese T; Nico B; Fumarulo R; Vacca A; Frassanito MA
Oncotarget; 2016 Sep; 7(37):60698-60711. PubMed ID: 27474171
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma.
Alipoor SD; Chang H
Cells; 2023 Mar; 12(7):. PubMed ID: 37048103
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
Desantis V; Saltarella I; Lamanuzzi A; Melaccio A; Solimando AG; Mariggiò MA; Racanelli V; Paradiso A; Vacca A; Frassanito MA
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]